UnitedHealth is well positioned for a potential recovery after two challenging years marked by cyberattacks, leadership turnover, and ongoing regulatory investigations. All major negative news appears ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

Despite robust 10-year revenue growth rate (9.17%), HUM's margins have declined due to rising policy benefits, high medical loss ratios, and increased utilization post-pandemic. HUM's margin ...

POLAND - 2025/09/07: In this photo illustration, the UnitedHealth Group company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty ...

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...

US stocks fell slightly on Tuesday, as Wall Street tried to regroup after a tech-led slide in the final stretch of 2025. The Federal Reserve's December meeting minutes showed a division among FOMC ...

U.S. healthcare spending is on a path that has finance leaders increasingly uneasy. With national health expenditures projected to reach $8.6 trillion by 2033 — and consume more than 20% of the nation ...

Prospects for an Enhanced Advance Premium Tax Credit extension have diminished, with early Idaho open enrollment period enrollment up 3% year over year but offset by expected non-effectuation, higher ...

The Centers for Medicare & Medicaid Services (CMS) has announced that the Center for Medicare and Medicaid Innovation is testing an outcome-aligned payment model known as the Advancing Chronic Care ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

After another year in which U.S. equity returns were largely driven by multiple expansion and an increasingly narrow group of mega-cap winners thriving on the AI narrative, the setup heading into 2026 ...